Compared to the usual care group , RAMP-DM group had lower cardiovascular events incidence ( 1.21 % vs 2.89 % , P = 0.003 ) , and net decrease in HbA1c ( -0.20 % , P < 0.01 ) , SBP ( -3.62 mmHg , P < 0.01 ) and 10-year cardiovascular disease ( CVD ) risks ( total CVD risk , -2.06 % , P < 0.01 ; coronary heart disease ( CHD ) risk , -1.43 % , P < 0.01 ; stroke risk , -0.71 % , P < 0.01 ) .